Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).

Journal of clinical pathology - 1 Mar 2006

Sonnweber B, Dlaska M, Skvortsov S, Dirnhofer S, Schmid T, Hilbe W

Abstract excerpt

AIMS: Overexpression and mutation of epidermal growth factor regulator (EGFR) are frequently found in the carcinogenesis of non-small cell lung cancer (NSCLC). Because targeting of this receptor has proven therapeutic efficacy, studying EGFR has become a matter of particular scientific interest. The present study analysed the EGFR receptor, rate of EGFRvIII mutations, and rate of activated phosphorylated EGFR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to ErbB Receptors

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Phosphorylation

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 16505275
DOI: 10.1136/jcp.2005.027615
PMCID: PMC1860345

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).PMID 16505275Read ↗

Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.Semantic proximity Read ↗

Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.Semantic proximity Read ↗

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.Semantic proximity Read ↗

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Phosphorylation status of epidermal growth factor receptor is closely associated with responsiveness to gefitinib in pulmonary adenocarcinoma.Semantic proximity Read ↗

EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations.Semantic proximity Read ↗

Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.Semantic proximity Read ↗

Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment.Semantic proximity Read ↗

Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.